Legacy Capital Group California, Inc. Novo Nordisk A S Transaction History
Legacy Capital Group California, Inc.
- $301 Billion
- Q3 2024
A detailed history of Legacy Capital Group California, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 7,610 shares of NVO stock, worth $861,832. This represents 0.3% of its overall portfolio holdings.
Number of Shares
7,610
Previous 14,609
47.91%
Holding current value
$861,832
Previous $2.09 Billion
56.55%
% of portfolio
0.3%
Previous 0.75%
Shares
7 transactions
Others Institutions Holding NVO
# of Institutions
1,963Shares Held
320MCall Options Held
5.16MPut Options Held
4.96M-
Jennison Associates LLC21.2MShares$2.4 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.65 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.61 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.51 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.42 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $256B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...